Adagio Medical Holdings, Inc (ADGM)
Nasdaq: ADGM · Surgical & Medical Instruments & Apparatus · Laguna Hills, CA · filing with the SEC since 2024
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 27, 2026 | Mar 27, 2025 | · |
| Revenue | 0 | · | 300 |
| Cost of revenue | 684 | · | 1,306 |
| Research and development | 10,639 | · | 15,399 |
| Selling, general and administrative | 10,567 | · | 11,537 |
| Total costs and expenses | 21,890 | · | 28,242 |
| Operating income | -21,890 | · | -27,942 |
| Interest expense | 2,906 | · | 1,659 |
| Interest and investment income | 477 | · | 3 |
| Other income (expense), net | 195 | · | -20 |
| Total non-operating income (expense) | -3,194 | · | -8,648 |
| Income before income taxes | -25,322 | · | -36,590 |
| Income tax expense | 0 | 0 | 0 |
| Net income including non-controlling interests | -25,084 | · | -36,590 |
| Net income | -25,084 | · | -36,590 |
| Net income to common shareholders | -25,084 | · | -36,590 |
| Earnings per share, basic | -1.51 | · | -48.16 |
| Earnings per share, diluted | -1.51 | · | -48.16 |
| Weighted average shares, basic | 16,577,126 | · | 759,814 |
| Weighted average shares, diluted | 16,577,126 | · | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding